Medecins Sans Frontieres: 870m Vaccine Doses Being Hoarded by 10 Rich Countries – ‘Tragedy’ for Those Deprived of Jabs 08/10/2021 Madeleine Hoecklin The hoarding of more than 870 million excess doses of COVID-19 vaccines in just 10 high-income countries is likely to deprive hundreds of millions of healthcare workers and vulnerable populations in low- and middle-income countries of the opportunity to get even a first vaccine dose, according to a new report by Medecins Sans Frontieres (MSF). […] Continue reading -> WHO Believes 70% Vaccination Target is Possible – But Only if Wealthy Countries Make Way for COVAX and Africa 07/10/2021 Kerry Cullinan The World Health Organization (WHO) believes that is possible to get 70% of the world vaccinated against COVID-19 by June – but only if wealthy countries redirect their doses and orders to poorer countries that are lagging behind. Eleven billion vaccines are needed to reach the 70% target, said WHO Director-General Dr Tedros Adhanom Ghebreyesus […] Continue reading -> ‘Constructive Tone’ Now Emerging Among World Trade Organization Members On IP Waiver for COVID Health Products 07/10/2021 Elaine Ruth Fletcher Discussions over a controversial World Trade Organization waiver on intellectual property related to COVID vaccines, treatments and other tools, have become more “constructive” said a senior WTO spokesman on Thursday, in a press briefing on the first day of the WTO’s two-day General Council meeting. There has been a “subtle shifting in the direction of […] Continue reading -> Moderna is Urged to Work Through African Partnership to Set up mRNA Facility 07/10/2021 Kerry Cullinan Moderna should work through the Partnership for African Vaccine Manufacturing (PAVM) if it wants to invest in vaccine production on the continent, according to the head of the Africa Centers for Disease Control (CDC). The company announced on Thursday that it plans to invest $500-million in a “state-of-the-art mRNA facility” in Africa that can produce […] Continue reading -> Jamaica, Nicaragua and Haiti Fail to Reach 10% COVID-19 Vaccination Target 07/10/2021 Raisa Santos Jamaica, Nicaragua, and Haiti were the only three member countries of the Pan American Health Organization (PAHO) that failed to meet the World Health Organization (WHO) target of vaccinating 10% of their populations against COVID-19 by the end of September. Around 37% of people in Latin America and the Caribbean have been fully vaccinated against […] Continue reading -> African Medicines Agency Will Come into Being on 5 November – after 15th African Country Ratifies & Deposits AMA Treaty 06/10/2021 Kerry Cullinan Africans are a step closer to speedier access to newer, safer medicines following this week’s notification by 15 African Union (AU) member countries that they have formally ratified and deposited their accord to create a new African Medicines Agency (AMA). Although the AU adopted the treaty to set up the AMA back in February 2019, […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> A New Pandemic Treaty, Revised International Health Regulations, or Both? What is the Actual Roadmap? 02/10/2021 Gian Luca Burci The World Health Assembly is set to make a fateful decision in November over whether to negotiate a new international ‘Pandemic Treaty’ to improve future pandemic preparedness and response. However, major players like the United States, backed by some civil society groups, have suggested that revisions of the existing International Health Regulations (IHR) would be […] Continue reading -> Tuberculosis is Here to Stay if We Don’t Mobilise Resources for Diagnoses and Double Fundings, New Data Shows 01/10/2021 Aishwarya Tendolkar The COVID-19 pandemic and the consequent diversion of resources toward battling SARS-CoV2 has also set back global efforts to eliminate the world’s second most deadly infectious killer: Tuberculosis, by 2030. Only a doubling of investments next year can pave the way to attainment of the 2030 United Nations Sustainable Development Goals to eliminate the disease, […] Continue reading -> New Social Contract and One Health Approach Critical to Resilient Recovery from COVID Pandemic 01/10/2021 Madeleine Hoecklin A new social contract between European governments and their citizens is needed to lay the foundation for a resilient and sustainable recovery from the COVID-19 pandemic, with health at the center, said panelists at the closing session of the European Health Forum Gastein (EHFG) on Friday. A focus on ensuring social protection and equitable access […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Believes 70% Vaccination Target is Possible – But Only if Wealthy Countries Make Way for COVAX and Africa 07/10/2021 Kerry Cullinan The World Health Organization (WHO) believes that is possible to get 70% of the world vaccinated against COVID-19 by June – but only if wealthy countries redirect their doses and orders to poorer countries that are lagging behind. Eleven billion vaccines are needed to reach the 70% target, said WHO Director-General Dr Tedros Adhanom Ghebreyesus […] Continue reading -> ‘Constructive Tone’ Now Emerging Among World Trade Organization Members On IP Waiver for COVID Health Products 07/10/2021 Elaine Ruth Fletcher Discussions over a controversial World Trade Organization waiver on intellectual property related to COVID vaccines, treatments and other tools, have become more “constructive” said a senior WTO spokesman on Thursday, in a press briefing on the first day of the WTO’s two-day General Council meeting. There has been a “subtle shifting in the direction of […] Continue reading -> Moderna is Urged to Work Through African Partnership to Set up mRNA Facility 07/10/2021 Kerry Cullinan Moderna should work through the Partnership for African Vaccine Manufacturing (PAVM) if it wants to invest in vaccine production on the continent, according to the head of the Africa Centers for Disease Control (CDC). The company announced on Thursday that it plans to invest $500-million in a “state-of-the-art mRNA facility” in Africa that can produce […] Continue reading -> Jamaica, Nicaragua and Haiti Fail to Reach 10% COVID-19 Vaccination Target 07/10/2021 Raisa Santos Jamaica, Nicaragua, and Haiti were the only three member countries of the Pan American Health Organization (PAHO) that failed to meet the World Health Organization (WHO) target of vaccinating 10% of their populations against COVID-19 by the end of September. Around 37% of people in Latin America and the Caribbean have been fully vaccinated against […] Continue reading -> African Medicines Agency Will Come into Being on 5 November – after 15th African Country Ratifies & Deposits AMA Treaty 06/10/2021 Kerry Cullinan Africans are a step closer to speedier access to newer, safer medicines following this week’s notification by 15 African Union (AU) member countries that they have formally ratified and deposited their accord to create a new African Medicines Agency (AMA). Although the AU adopted the treaty to set up the AMA back in February 2019, […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> A New Pandemic Treaty, Revised International Health Regulations, or Both? What is the Actual Roadmap? 02/10/2021 Gian Luca Burci The World Health Assembly is set to make a fateful decision in November over whether to negotiate a new international ‘Pandemic Treaty’ to improve future pandemic preparedness and response. However, major players like the United States, backed by some civil society groups, have suggested that revisions of the existing International Health Regulations (IHR) would be […] Continue reading -> Tuberculosis is Here to Stay if We Don’t Mobilise Resources for Diagnoses and Double Fundings, New Data Shows 01/10/2021 Aishwarya Tendolkar The COVID-19 pandemic and the consequent diversion of resources toward battling SARS-CoV2 has also set back global efforts to eliminate the world’s second most deadly infectious killer: Tuberculosis, by 2030. Only a doubling of investments next year can pave the way to attainment of the 2030 United Nations Sustainable Development Goals to eliminate the disease, […] Continue reading -> New Social Contract and One Health Approach Critical to Resilient Recovery from COVID Pandemic 01/10/2021 Madeleine Hoecklin A new social contract between European governments and their citizens is needed to lay the foundation for a resilient and sustainable recovery from the COVID-19 pandemic, with health at the center, said panelists at the closing session of the European Health Forum Gastein (EHFG) on Friday. A focus on ensuring social protection and equitable access […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
‘Constructive Tone’ Now Emerging Among World Trade Organization Members On IP Waiver for COVID Health Products 07/10/2021 Elaine Ruth Fletcher Discussions over a controversial World Trade Organization waiver on intellectual property related to COVID vaccines, treatments and other tools, have become more “constructive” said a senior WTO spokesman on Thursday, in a press briefing on the first day of the WTO’s two-day General Council meeting. There has been a “subtle shifting in the direction of […] Continue reading -> Moderna is Urged to Work Through African Partnership to Set up mRNA Facility 07/10/2021 Kerry Cullinan Moderna should work through the Partnership for African Vaccine Manufacturing (PAVM) if it wants to invest in vaccine production on the continent, according to the head of the Africa Centers for Disease Control (CDC). The company announced on Thursday that it plans to invest $500-million in a “state-of-the-art mRNA facility” in Africa that can produce […] Continue reading -> Jamaica, Nicaragua and Haiti Fail to Reach 10% COVID-19 Vaccination Target 07/10/2021 Raisa Santos Jamaica, Nicaragua, and Haiti were the only three member countries of the Pan American Health Organization (PAHO) that failed to meet the World Health Organization (WHO) target of vaccinating 10% of their populations against COVID-19 by the end of September. Around 37% of people in Latin America and the Caribbean have been fully vaccinated against […] Continue reading -> African Medicines Agency Will Come into Being on 5 November – after 15th African Country Ratifies & Deposits AMA Treaty 06/10/2021 Kerry Cullinan Africans are a step closer to speedier access to newer, safer medicines following this week’s notification by 15 African Union (AU) member countries that they have formally ratified and deposited their accord to create a new African Medicines Agency (AMA). Although the AU adopted the treaty to set up the AMA back in February 2019, […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> A New Pandemic Treaty, Revised International Health Regulations, or Both? What is the Actual Roadmap? 02/10/2021 Gian Luca Burci The World Health Assembly is set to make a fateful decision in November over whether to negotiate a new international ‘Pandemic Treaty’ to improve future pandemic preparedness and response. However, major players like the United States, backed by some civil society groups, have suggested that revisions of the existing International Health Regulations (IHR) would be […] Continue reading -> Tuberculosis is Here to Stay if We Don’t Mobilise Resources for Diagnoses and Double Fundings, New Data Shows 01/10/2021 Aishwarya Tendolkar The COVID-19 pandemic and the consequent diversion of resources toward battling SARS-CoV2 has also set back global efforts to eliminate the world’s second most deadly infectious killer: Tuberculosis, by 2030. Only a doubling of investments next year can pave the way to attainment of the 2030 United Nations Sustainable Development Goals to eliminate the disease, […] Continue reading -> New Social Contract and One Health Approach Critical to Resilient Recovery from COVID Pandemic 01/10/2021 Madeleine Hoecklin A new social contract between European governments and their citizens is needed to lay the foundation for a resilient and sustainable recovery from the COVID-19 pandemic, with health at the center, said panelists at the closing session of the European Health Forum Gastein (EHFG) on Friday. A focus on ensuring social protection and equitable access […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Moderna is Urged to Work Through African Partnership to Set up mRNA Facility 07/10/2021 Kerry Cullinan Moderna should work through the Partnership for African Vaccine Manufacturing (PAVM) if it wants to invest in vaccine production on the continent, according to the head of the Africa Centers for Disease Control (CDC). The company announced on Thursday that it plans to invest $500-million in a “state-of-the-art mRNA facility” in Africa that can produce […] Continue reading -> Jamaica, Nicaragua and Haiti Fail to Reach 10% COVID-19 Vaccination Target 07/10/2021 Raisa Santos Jamaica, Nicaragua, and Haiti were the only three member countries of the Pan American Health Organization (PAHO) that failed to meet the World Health Organization (WHO) target of vaccinating 10% of their populations against COVID-19 by the end of September. Around 37% of people in Latin America and the Caribbean have been fully vaccinated against […] Continue reading -> African Medicines Agency Will Come into Being on 5 November – after 15th African Country Ratifies & Deposits AMA Treaty 06/10/2021 Kerry Cullinan Africans are a step closer to speedier access to newer, safer medicines following this week’s notification by 15 African Union (AU) member countries that they have formally ratified and deposited their accord to create a new African Medicines Agency (AMA). Although the AU adopted the treaty to set up the AMA back in February 2019, […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> A New Pandemic Treaty, Revised International Health Regulations, or Both? What is the Actual Roadmap? 02/10/2021 Gian Luca Burci The World Health Assembly is set to make a fateful decision in November over whether to negotiate a new international ‘Pandemic Treaty’ to improve future pandemic preparedness and response. However, major players like the United States, backed by some civil society groups, have suggested that revisions of the existing International Health Regulations (IHR) would be […] Continue reading -> Tuberculosis is Here to Stay if We Don’t Mobilise Resources for Diagnoses and Double Fundings, New Data Shows 01/10/2021 Aishwarya Tendolkar The COVID-19 pandemic and the consequent diversion of resources toward battling SARS-CoV2 has also set back global efforts to eliminate the world’s second most deadly infectious killer: Tuberculosis, by 2030. Only a doubling of investments next year can pave the way to attainment of the 2030 United Nations Sustainable Development Goals to eliminate the disease, […] Continue reading -> New Social Contract and One Health Approach Critical to Resilient Recovery from COVID Pandemic 01/10/2021 Madeleine Hoecklin A new social contract between European governments and their citizens is needed to lay the foundation for a resilient and sustainable recovery from the COVID-19 pandemic, with health at the center, said panelists at the closing session of the European Health Forum Gastein (EHFG) on Friday. A focus on ensuring social protection and equitable access […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Jamaica, Nicaragua and Haiti Fail to Reach 10% COVID-19 Vaccination Target 07/10/2021 Raisa Santos Jamaica, Nicaragua, and Haiti were the only three member countries of the Pan American Health Organization (PAHO) that failed to meet the World Health Organization (WHO) target of vaccinating 10% of their populations against COVID-19 by the end of September. Around 37% of people in Latin America and the Caribbean have been fully vaccinated against […] Continue reading -> African Medicines Agency Will Come into Being on 5 November – after 15th African Country Ratifies & Deposits AMA Treaty 06/10/2021 Kerry Cullinan Africans are a step closer to speedier access to newer, safer medicines following this week’s notification by 15 African Union (AU) member countries that they have formally ratified and deposited their accord to create a new African Medicines Agency (AMA). Although the AU adopted the treaty to set up the AMA back in February 2019, […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> A New Pandemic Treaty, Revised International Health Regulations, or Both? What is the Actual Roadmap? 02/10/2021 Gian Luca Burci The World Health Assembly is set to make a fateful decision in November over whether to negotiate a new international ‘Pandemic Treaty’ to improve future pandemic preparedness and response. However, major players like the United States, backed by some civil society groups, have suggested that revisions of the existing International Health Regulations (IHR) would be […] Continue reading -> Tuberculosis is Here to Stay if We Don’t Mobilise Resources for Diagnoses and Double Fundings, New Data Shows 01/10/2021 Aishwarya Tendolkar The COVID-19 pandemic and the consequent diversion of resources toward battling SARS-CoV2 has also set back global efforts to eliminate the world’s second most deadly infectious killer: Tuberculosis, by 2030. Only a doubling of investments next year can pave the way to attainment of the 2030 United Nations Sustainable Development Goals to eliminate the disease, […] Continue reading -> New Social Contract and One Health Approach Critical to Resilient Recovery from COVID Pandemic 01/10/2021 Madeleine Hoecklin A new social contract between European governments and their citizens is needed to lay the foundation for a resilient and sustainable recovery from the COVID-19 pandemic, with health at the center, said panelists at the closing session of the European Health Forum Gastein (EHFG) on Friday. A focus on ensuring social protection and equitable access […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
African Medicines Agency Will Come into Being on 5 November – after 15th African Country Ratifies & Deposits AMA Treaty 06/10/2021 Kerry Cullinan Africans are a step closer to speedier access to newer, safer medicines following this week’s notification by 15 African Union (AU) member countries that they have formally ratified and deposited their accord to create a new African Medicines Agency (AMA). Although the AU adopted the treaty to set up the AMA back in February 2019, […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> A New Pandemic Treaty, Revised International Health Regulations, or Both? What is the Actual Roadmap? 02/10/2021 Gian Luca Burci The World Health Assembly is set to make a fateful decision in November over whether to negotiate a new international ‘Pandemic Treaty’ to improve future pandemic preparedness and response. However, major players like the United States, backed by some civil society groups, have suggested that revisions of the existing International Health Regulations (IHR) would be […] Continue reading -> Tuberculosis is Here to Stay if We Don’t Mobilise Resources for Diagnoses and Double Fundings, New Data Shows 01/10/2021 Aishwarya Tendolkar The COVID-19 pandemic and the consequent diversion of resources toward battling SARS-CoV2 has also set back global efforts to eliminate the world’s second most deadly infectious killer: Tuberculosis, by 2030. Only a doubling of investments next year can pave the way to attainment of the 2030 United Nations Sustainable Development Goals to eliminate the disease, […] Continue reading -> New Social Contract and One Health Approach Critical to Resilient Recovery from COVID Pandemic 01/10/2021 Madeleine Hoecklin A new social contract between European governments and their citizens is needed to lay the foundation for a resilient and sustainable recovery from the COVID-19 pandemic, with health at the center, said panelists at the closing session of the European Health Forum Gastein (EHFG) on Friday. A focus on ensuring social protection and equitable access […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> A New Pandemic Treaty, Revised International Health Regulations, or Both? What is the Actual Roadmap? 02/10/2021 Gian Luca Burci The World Health Assembly is set to make a fateful decision in November over whether to negotiate a new international ‘Pandemic Treaty’ to improve future pandemic preparedness and response. However, major players like the United States, backed by some civil society groups, have suggested that revisions of the existing International Health Regulations (IHR) would be […] Continue reading -> Tuberculosis is Here to Stay if We Don’t Mobilise Resources for Diagnoses and Double Fundings, New Data Shows 01/10/2021 Aishwarya Tendolkar The COVID-19 pandemic and the consequent diversion of resources toward battling SARS-CoV2 has also set back global efforts to eliminate the world’s second most deadly infectious killer: Tuberculosis, by 2030. Only a doubling of investments next year can pave the way to attainment of the 2030 United Nations Sustainable Development Goals to eliminate the disease, […] Continue reading -> New Social Contract and One Health Approach Critical to Resilient Recovery from COVID Pandemic 01/10/2021 Madeleine Hoecklin A new social contract between European governments and their citizens is needed to lay the foundation for a resilient and sustainable recovery from the COVID-19 pandemic, with health at the center, said panelists at the closing session of the European Health Forum Gastein (EHFG) on Friday. A focus on ensuring social protection and equitable access […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
A New Pandemic Treaty, Revised International Health Regulations, or Both? What is the Actual Roadmap? 02/10/2021 Gian Luca Burci The World Health Assembly is set to make a fateful decision in November over whether to negotiate a new international ‘Pandemic Treaty’ to improve future pandemic preparedness and response. However, major players like the United States, backed by some civil society groups, have suggested that revisions of the existing International Health Regulations (IHR) would be […] Continue reading -> Tuberculosis is Here to Stay if We Don’t Mobilise Resources for Diagnoses and Double Fundings, New Data Shows 01/10/2021 Aishwarya Tendolkar The COVID-19 pandemic and the consequent diversion of resources toward battling SARS-CoV2 has also set back global efforts to eliminate the world’s second most deadly infectious killer: Tuberculosis, by 2030. Only a doubling of investments next year can pave the way to attainment of the 2030 United Nations Sustainable Development Goals to eliminate the disease, […] Continue reading -> New Social Contract and One Health Approach Critical to Resilient Recovery from COVID Pandemic 01/10/2021 Madeleine Hoecklin A new social contract between European governments and their citizens is needed to lay the foundation for a resilient and sustainable recovery from the COVID-19 pandemic, with health at the center, said panelists at the closing session of the European Health Forum Gastein (EHFG) on Friday. A focus on ensuring social protection and equitable access […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Tuberculosis is Here to Stay if We Don’t Mobilise Resources for Diagnoses and Double Fundings, New Data Shows 01/10/2021 Aishwarya Tendolkar The COVID-19 pandemic and the consequent diversion of resources toward battling SARS-CoV2 has also set back global efforts to eliminate the world’s second most deadly infectious killer: Tuberculosis, by 2030. Only a doubling of investments next year can pave the way to attainment of the 2030 United Nations Sustainable Development Goals to eliminate the disease, […] Continue reading -> New Social Contract and One Health Approach Critical to Resilient Recovery from COVID Pandemic 01/10/2021 Madeleine Hoecklin A new social contract between European governments and their citizens is needed to lay the foundation for a resilient and sustainable recovery from the COVID-19 pandemic, with health at the center, said panelists at the closing session of the European Health Forum Gastein (EHFG) on Friday. A focus on ensuring social protection and equitable access […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
New Social Contract and One Health Approach Critical to Resilient Recovery from COVID Pandemic 01/10/2021 Madeleine Hoecklin A new social contract between European governments and their citizens is needed to lay the foundation for a resilient and sustainable recovery from the COVID-19 pandemic, with health at the center, said panelists at the closing session of the European Health Forum Gastein (EHFG) on Friday. A focus on ensuring social protection and equitable access […] Continue reading -> Posts navigation Older postsNewer posts